Abstract: An inertia braking test system and a control method is provided, wherein the inertia braking test system is composed of an inertia brake test system, a sensor system and a tested object. An actuating device is connected with the inertia brake control device through a ball stud. The actuation function of the inertia brake control device with two degrees of freedom along the front-and-rear direction and the up-and-down direction of the vehicle is realized. The movable chassis realizes the mobile function of the system. The acceleration sensor can sense the acceleration of the movable chassis. Each force is tested by the first force sensor, the second force sensor and the third force sensor. The displacement data is measured by the first displacement sensor and the second displacement sensor, so that a movable brake system test is achieved.

Abstract: An animation display method is provided. In the method, a first display area is displayed on a game setting interface of a game application. The first display area is configured to display a first operation flow in the game application. A first picture is displayed in the first display area when the first display area is not selected. The first picture is at least one display picture in the first operation flow. A first animation is played in the first display area when the first display area is selected. The first animation plays at least one group of display pictures in the first operation flow.

Abstract: An organic light emitting diode (OLED) display device and a method of manufacturing thereof are provided. The organic light emitting diode display device includes a display area and a non-display area. The display area includes a pixel area and a photosensitive area disposed between the pixel areas. The photosensitive area includes a first thin film transistor. The pixel area includes a second thin film transistor, which the same type as the first thin film transistor. The non-display area includes a third thin film transistor, which is a different type from the first thin film transistor.

Abstract: Under Backend Application Session Management (“BASM”), a DBMS not only creates an application session but also the respective adjunct security context to which to attach the adjunct security context. The middle tier does not need to create the application session or its adjunct security context. Instead, the middle tier sends an end-user token that the middle tier piggybacks to database requests that are sent through database connections. The end-user token identifies an end user and has been authenticated by the middle tier. The generation of the end-user token is concomitant to the process of the middle tier authenticating the end user. The DBMS invokes a user-defined function to generate an adjunct security context. The user-defined function generates the adjunct security context based on the end-user token. Application developers can customize the user-defined function to customize backend security for their needs.

Abstract: The present disclosure disclosed recombinase aided amplification (RAA) primers and kits for the detection of hepatitis c virus. Nucleotide sequences of the RAA primers include: an upstream primer: 5?-FITC-CTTGGGATATGATGATGAACTGGTCACCTAC-3? (SEQ ID NO. 1); and a downstream primer: 5?-Biotin-AAGAGTAGCATCACAATCAGAACCTTAGCC-3? (SEQ ID NO. 2). The HCV detection by using the RAA primers screened by the present disclosure has good specificity and high sensitivity (at least 10 copies/?L can be detected). The RAA primers can be used to prepare an HCV detection kit and construct an RAA amplification system. And combined with a lateral flow chromatography technology, the present disclosure can achieve rapid and low-cost detection of HCV and visual result judgment, no complex professional background is required, the use process is convenient and fast, and the detection results are safe and reliable.

Abstract: A medical polyurethane foam dressing and a preparation method thereof are provided in this disclosure. The medical polyurethane foam dressing includes a polyurethane film, a hydrophilic polyurethane foam layer compounded on the polyurethane film, a release paper provided on the hydrophilic polyurethane foam layer, and a soft silicone composite layer located below the release paper. The polyurethane film consists of a release film and a PU resin layer or TPU resin layer coated on the release film. Products prepared according to the disclosure not only can serve to absorb wound exudate of pressure sore, but also provides single-side water proofing; and it is sticky and can be stably fixed on the wound without easy displacement, thus ensuring continuous and stable liquid absorption.

Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, including but not limited to leukemia, myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN); and diabetes.

Abstract: Disclosed is a compound of Formula I: useful as emitters in OLEDs; where the variables in Formula I are defined in the present disclosure.

Abstract: The present invention provides a pharmaceutical composition for treating chronic stroke, involving injection via brain into the cranium of a patient having chronic stroke for six months or more; the pharmaceutical composition is a suspension at least comprising TS stem cells, an active synergistic component and a growth factor, wherein the expression level of CD34 and CD45 of the TS stem cells is 10% or less, and the expression level of CD90 and CD105 is 90% or more; the active synergistic component is an extracellular vesicle; the growth factor is at least one selected from the group consisting of HGF, G-CSF, Fractalkine, IP-10, EGF, IL-1?, IL-1?, IL-4, IL-5, IL-13, IFN?, TGF? and sCD40L. The present invention overcomes the limitations of previous cell therapy and provides a cell-based preparation that is clinically safe and therapeutically effective for chronic cerebral stroke.

Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

Abstract: A predictive maintenance system and method for intelligent manufacturing equipment is provided. The predictive maintenance system includes a first-stage predictive maintenance module, a second-stage predictive maintenance module, and a maintenance decision module. The first-stage predictive maintenance module includes an acquisition module, a human-computer interaction module, a calculation module, and a storage module. The second-stage predictive maintenance module includes a communication module, a setting module, and a prediction module. The maintenance decision module is configured to receive a first-stage remaining service life calculated by the first-stage predictive maintenance module and a second-stage remaining service life predicted by the second-stage predictive maintenance module, and determine a predictive maintenance strategy of the intelligent manufacturing equipment according to the first-stage remaining service life and the second-stage remaining service life.

Abstract: The present disclosure provides an array substrate and a display panel. The array substrate includes a base substrate and at least one signal line unit in a fan-out region of the base substrate. Each of the at least one signal line unit includes two first signal lines and one second signal line, and the two first signal lines and the one second signal line are respectively in different layers and extend in a same direction. A center line of an orthographic projection of the one second signal line on the base substrate overlaps with a center line of an orthographic projection of an interval region between the two first signal lines.

Abstract: Provided are dihydropyrimidine derivatives which are useful in the treatment or prevention of HBV infection or of HBV-induced diseases, more particularly of HBV chronic infection or of diseases induced by HBV chronic infection, as well as pharmaceutical or medical applications thereof.

Abstract: Provided is a touch display substrate. The touch display substrate includes a base substrate, including a display region and a non-display region; a plurality of touch electrodes disposed in the display region; and a plurality of signal transmission circuits, a plurality of first control lines, a plurality of second control lines, a target signal line, and a plurality of touch signal lines that are disposed in the non-display region.

Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

Abstract: Methods, systems, and apparatus, including biological fluid monitoring systems comprising a microneedle layer; at least one electromagnet assembly; and at least two liquid chambers coupled via a microfluidic layer, wherein the microneedle layer comprises a plurality of microneedles configured to extract interstitial fluid (ISF) from a patient in to one of the at least two liquid chambers, and wherein the at least one electromagnet assembly is configured to a move a test sample of the extracted ISF through the at least two liquid chambers to conduct a test cycle.

Abstract: The application describes dihydropyrimidine derivatives which are useful in the treatment or prevention of HBV infection or of HBV-induced diseases, more particularly of HBV chronic infection or of diseases induced by HBV chronic infection, as well as pharmaceutical or medical applications thereof.

Abstract: An organic light emitting diode (OLED) display device and a method of manufacturing thereof are provided. The organic light emitting diode display device includes a display area and a non-display area. The display area includes a pixel area and a photosensitive area disposed between the pixel areas. The photosensitive area includes a first thin film transistor. The pixel area includes a second thin film transistor, which the same type as the first thin film transistor. The non-display area includes a third thin film transistor, which is a different type from the first thin film transistor.

Abstract: A cryogenic vaporization system and method are provided. A first heat exchanger heats a liquid cryogen via indirect heat exchange to output a cryogenic vapor at a first temperature. A second heat exchanger receives the cryogenic vapor at the first temperature. The second heat exchanger heats the cryogenic vapor via indirect heat exchange to a second temperature. The cryogenic vapor at the second temperature is recirculated to the first heat exchanger to heat the liquid cryogen and cool the recirculated cryogenic vapor to a third temperature. A third heat exchanger receives the cryogenic vapor at the third temperature. The third heat exchanger heats the cryogenic vapor to a fourth temperature. The third heat exchanger outputs the cryogenic vapor at the fourth temperature.